The largest database of trusted experimental protocols

D5 lxa4

Manufactured by Cayman Chemical
Sourced in Germany

D5-LXA4 is a chemical compound used in research laboratory applications. It is a synthetic analog of the natural lipid mediator Leukotriene A4 (LTA4). The core function of D5-LXA4 is to serve as a research tool for investigating the biological activities and signaling pathways associated with LTA4 and related eicosanoid molecules.

Automatically generated - may contain errors

7 protocols using d5 lxa4

1

Targeted Lipidomic Analysis of RAW264.7 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PCM prepared in phenol red-free media was added to 100% methanol (1:2) and stored at −80°C. Similarly, phenol red-free media from RAW264.7 cells exposed to PCM +/− PGE2 antibody for 6 hours was added to 100% methanol and stored at −80°C. These samples were then subjected to solid-phase extraction followed by targeted LC-MS/MS analysis as previously described in detail [16 ]. Extraction recovery was aided by deuterium-labeled internal standards for each chromatographic region including d4-PGE2 and d5-LXA4 (Cayman Chemical), and lipid mediators were identified and quantified using multiple reaction monitoring transitions and full MS/MS spectra as compared with authentic external standards (Supplemental Figure 3). For visualization, a heatmap of all identified lipid mediators was constructed using Metaboanalyst (www.Metaboanalyst.ca). For this, a missing value imputation was first performed followed by a generalized log transformation and autoscaling. Finally, Ward clustering algorithm and Euclidean distance measures was applied to data. The resulting heatmap illustrates the relative change in abundance of individual mediators across each experimental condition.
+ Open protocol
+ Expand
2

Macrophage-E. coli Interaction Lipidome

Check if the same lab product or an alternative is used in the 5 most similar protocols
Macrophages (2x106 cells) were incubated with E. coli (1x107 cells) for 30 minutes at 37°C. Incubations were quenched using two volumes of ice-cold methanol containing deuterium labelled internal standards (500 pg each of d4-PGE2, d5-LXA4, d4-RvD2, d4-LTB4 and d8-5S-HETE, Cayman Chemicals). Samples were then stored at -20°C prior to extraction and lipid mediator profiling.
+ Open protocol
+ Expand
3

Lipidomic Analysis of Inflammatory Mediators

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples were taken to solid-phase extraction (SPE) using Isolute C18 SPE 3 mL cartridges (Biotage, USA), as in Colas et al.15 (link). Briefly, internal standards (d8-5-HETE, d5-RvD2, d5-LXA4, d4-LTB4, d4-PGE2; 500 pg each; Cayman Chemicals, USA) were added along with four volumes of methanol before SPE, and covered on ice for 30-60 minutes to allow for protein precipitation. During SPE, 6 mL of water was eluted through each cartridge, followed by elution of 6 mL of hexane. Lipid mediators were collected by elution and collection of 6 mL of methyl formate. Methyl formate fractions from SPE were analyzed by a liquid chromatography-tandem mass spectrometry system, QTrap 5500 (AB Sciex) equipped with a Shimadzu LC-20AD HPLC (Tokyo, Japan). A Poroshell 120 EC-18 column (100 mm × 4.6 mm × 2.7 μm; Agilent Technologies, USA) was kept in a column oven maintained at 50°C, and lipid mediators (LMs) were eluted in a gradient of methanol/water/acetic acid from 55:45:0.01 (v/v/v) to 98:2:0.01 at 0.5 mL/min flow rate. In order to monitor and quantify the levels of targeted LMs, multiple reaction monitoring (MRM) was used with MS/MS matching signature ion fragments for each molecule (at least six diagnostic ions; ~0.1 pg limits of detection) and standard curves (r2>0.98 for each lipid mediator and pathway marker).
+ Open protocol
+ Expand
4

Lipid Mediator Extraction and Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Freshly isolated PMNL and monocytes as well as polarized MDMs and HEK293 cells (1 or 2 × 106 in 1 mL, as indicated) were incubated in PG buffer containing 1 mm CaCl2. In some experiments, cells were incubated in PG buffer containing 0.5 mm EDTA or 0.5 mm EDTA plus BAPTA/AM (20 µm). AKBA and other compounds, E. coli (O6:K2:H1; ratio 1:50) or vehicle (0.1% DMSO) as well as AA, EPA, and DHA were added at 37 °C as indicated. After the indicated (pre‐)incubation times, the supernatants (1 mL) were mixed with 2 mL of ice‐cold methanol that contained deuterium‐labeled internal standards (200 nm d4‐PGE2, d4‐LTB4, d5‐LXA4, d5‐RvD2, and d8‐5S‐HETE, as well as 10 µm d8‐AA; Cayman Chemical/Biomol GmbH, Hamburg, Germany). Solid phase extraction (SPE) of LM, sample preparation, and UPLC‐MS‐MS analysis of LM was performed as described by Jordan et al.[15]
+ Open protocol
+ Expand
5

Lipid Mediator Quantification by LC-MS/MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
LC-MS-MS data acquisition and analyses were performed as described previously31 (link),47 (link). Briefly, to facilitate lipid mediator quantitation and sample recovery, 5 deuterium labeled internal standards were added to each sample: d8-5-HETE, d5-RvD2, d5-LXA4, d4-LTB4, d4-PGE2 (500 pg each; Cayman). Samples were then injected into the LC-MS-MS system, which consisted of a Qtrap 5500 (Sciex, Framingham, MA) equipped with a Shimadzu LC-20AD HPLC (Tokyo, Japan) and data was acquired with parameters described previously31 (link),47 (link). Targeted MRM (multiple reaction monitoring) was utilized to quantify the lipid mediator levels. Lipid mediators below the limit of detection (~0.1 pg) were deemed to be non-detectable. Data analysis was performed on the Sciex software platform (Analyst version 1.6).
+ Open protocol
+ Expand
6

Quantification of Lipid Mediators in Monocytes and MDMs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Monocytes and MDM subsets (2 × 106/mL) were incubated in 1 mL PBS containing 1 mM CaCl2 with E. coli (O6:K2:H1; ratio = 1:50) or 0.5% ECM at 37 °C. After the indicated incubation periods, the supernatants (1 mL) were transferred to 2 mL of ice-cold methanol containing 10 µL of deuterium-labeled internal standards (200 nM d8-5S-HETE, d4-LTB4, d5-LXA4, d5-RvD2, d4-PGE2 and 10 µM d8-AA; Cayman Chemical/Biomol GmbH, Hamburg, Germany) to facilitate LM quantification and sample recovery. Solid phase extraction of LM, sample preparation, and UPLC-MS-MS analysis of LM was conducted exactly as reported in Jordan et al. (43 (link)).
To consider reduced numbers of adherent MDM after GC-treatment (17 (link)) during stimulation with E. coli for LM analysis, the total protein amount was determined for all samples using a modified Lowry Protein Assay employing DC Protein Assay Reagents Package (#5000116, Bio Rad, Hercules, CA). LM formation, given in pg, was normalized to total protein amount adjusted to 0.15 mg (corresponding to the mean protein amount of 2 × 106 plated MDM 48 h prior determination) or 1 mg, as indicated.
+ Open protocol
+ Expand
7

Extraction and Quantification of Lipid Mediators

Check if the same lab product or an alternative is used in the 5 most similar protocols
LMs were extracted from cell culture supernatants as described [26 (link)]. In brief, supernatants were transferred to ice-cold methanol (supernatant/methanol = 40/60) containing deuterium-labeled internal standards (200 nM d8-5S-HETE, d4-LTB4, d5-LXA4, d5-RvD2, d4-PGE2, and 10 μM d8-AA; Cayman Chemical/Biomol, Hamburg, Germany). After protein precipitation at −20 °C, samples were centrifuged, acidified (pH 3.5) and subjected to solid phase extraction (Sep-Pak® Vac 6 cc 500 mg/6 mL C18; Waters, Milford, USA). The cartridges were successively washed with methanol and n-hexane, and LMs were eluted with methyl formiate. Eluates were evaporated to dryness (TurboVap LV, Biotage, Uppsala, Sweden) and LMs taken up in methanol/water (50/50) for UPLC-MS/MS analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!